Michael Schlichting
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Eric Van Cutsem (15 shared papers)Philippe Rougier (4 shared papers)Gunnar Folprecht (5 shared papers)Claus-Henning Köhne (2 shared papers)Ilhan Celik (4 shared papers)Sabine Tejpar (5 shared papers)Sabine Tejpar (1 shared paper)Geert D’Haens (1 shared paper)
- Journals
- Journal of Clinical Oncology (16 papers)Annals of Oncology (4 papers)Value in Health (4 papers)Future Oncology (3 papers)Health and Quality of Life Outcomes (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Schlichting
43 papers receiving 6.3k citations
Michael Schlichting's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 4.5k
- Hepatology 971
- Pathology and Forensic Medicine 1.1k
- Cancer Research 792
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Michael Schlichting
This map shows the geographic impact of Michael Schlichting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schlichting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schlichting more than expected).
Fields of papers citing papers by Michael Schlichting
This network shows the impact of papers produced by Michael Schlichting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schlichting. The network helps show where Michael Schlichting may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Schlichting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 3017 |
| 2 | Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status Hit paper breakdown → | 2011 | 1498 |
| 3 | Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study Hit paper breakdown → | 2017 | 477 |
| 4 | Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials Hit paper breakdown → | 2012 | 461 |
| 5 | 2012 | 290 | |
| 6 | 2013 | 172 | |
| 7 | 2012 | 97 | |
| 8 | 2021 | 93 | |
| 9 | 2016 | 50 | |
| 10 | 2016 | 26 | |
| 11 | 2020 | 26 | |
| 12 | 2013 | 21 | |
| 13 | 2017 | 21 | |
| 14 | 2019 | 18 | |
| 15 | 2022 | 18 | |
| 16 | 2019 | 15 | |
| 17 | 2020 | 14 | |
| 18 | 2017 | 13 | |
| 19 | 2017 | 11 | |
| 20 | 2022 | 10 |
About Michael Schlichting
Michael Schlichting is a scholar working on Oncology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 45 papers that have together received 6.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Polyomavirus and related diseases (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (4.5k citations), Hepatology (971 citations), Pathology and Forensic Medicine (1.1k citations), Cancer Research (792 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Michael Schlichting has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Eric Van Cutsem, Philippe Rougier, Gunnar Folprecht, Claus-Henning Köhne, Ilhan Celik, Sabine Tejpar, Sabine Tejpar, Geert D’Haens, Erika Hitre and Anatoly Makhson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Value in Health, Future Oncology and Health and Quality of Life Outcomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.